Literature DB >> 21377315

Myositis or dystrophy? Traps and pitfalls.

Olivier Benveniste1, Norma B Romero.   

Abstract

Some hereditary myopathies can mimic acquired myositis especially when they first present in adulthood with a limb-girdle distribution of weakness. Although inherited myopathies are generally painless and progress very slowly there are exceptions, which can further add to diagnostic confusion. The diagnosis is made even more difficult when inflammatory infiltrates are present on muscle biopsy. This is common in certain dystrophies in particular e.g. dysferlinopathies or facioscapulohumeral dystrophy. On the other hand, acquired (and treatable with immunosuppressants) necrotizing myopathies with anti-SRP antibodies can be very slowly progressive, with clinical and pathological features compatible with limb girdle dystrophies. These two situations can lead to either inappropriate immunosuppressant treatment in a patient with dystrophy, having mistaken it for an acquired inflammatory myopathy, or to therapeutic abstention in a patient with a treatable acquired myopathy thinking that it was a dystrophy. Pointers helping to distinguish between these two traps are here reviewed.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21377315     DOI: 10.1016/j.lpm.2010.11.023

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  8 in total

Review 1.  Axons to Exons: the Molecular Diagnosis of Rare Neurological Diseases by Next-Generation Sequencing.

Authors:  Jodi Warman Chardon; Chandree Beaulieu; Taila Hartley; Kym M Boycott; David A Dyment
Journal:  Curr Neurol Neurosci Rep       Date:  2015-09       Impact factor: 5.081

Review 2.  Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum".

Authors:  Philip D H Hamann; Robert G Cooper; Neil J McHugh; Hector Chinoy
Journal:  Autoimmun Rev       Date:  2013-07-11       Impact factor: 9.754

Review 3.  Dysferlinopathy misdiagnosed with juvenile polymyositis in the pre-symptomatic stage of hyperCKemia: a case report and literature review.

Authors:  Cecilia Contreras-Cubas; Francisco Barajas-Olmos; Maria Inés Frayre-Martínez; Georgina Siordia-Reyes; Claudia C Guízar-Sánchez; Humberto García-Ortiz; Lorena Orozco; Vicente Baca
Journal:  BMC Med Genomics       Date:  2022-06-20       Impact factor: 3.622

4.  Clinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophy.

Authors:  Gulnara Mamyrova; James D Katz; Robert V Jones; Ira N Targoff; Peter A Lachenbruch; Olcay Y Jones; Frederick W Miller; Lisa G Rider
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-12       Impact factor: 4.794

5.  The CELF1 RNA-Binding Protein Regulates Decay of Signal Recognition Particle mRNAs and Limits Secretion in Mouse Myoblasts.

Authors:  Joseph Russo; Jerome E Lee; Carolina M López; John Anderson; Thuy-Mi P Nguyen; Adam M Heck; Jeffrey Wilusz; Carol J Wilusz
Journal:  PLoS One       Date:  2017-01-27       Impact factor: 3.240

6.  Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy.

Authors:  Payam Mohassel; Océane Landon-Cardinal; A Reghan Foley; Sandra Donkervoort; Katherine S Pak; Colleen Wahl; Robert T Shebert; Amy Harper; Pierre Fequiere; Matthew Meriggioli; Camilo Toro; Daniel Drachman; Yves Allenbach; Olivier Benveniste; Anthony Béhin; Bruno Eymard; Pascal Lafôret; Tanya Stojkovic; Andrew L Mammen; Carsten G Bönnemann
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-12-12

7.  Eosinophils in hereditary and inflammatory myopathies.

Authors:  Thomas Schröder; Johann Fuchss; Ilka Schneider; Gisela Stoltenburg-Didinger; Frank Hanisch
Journal:  Acta Myol       Date:  2013-12

8.  Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy.

Authors:  Metha Apiwattanakul; Margherita Milone; Sean J Pittock; Thomas J Kryzer; James P Fryer; Orna O'toole; Andrew Mckeon; Vanda A Lennon
Journal:  Muscle Nerve       Date:  2016-02-05       Impact factor: 3.217

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.